Delayed Diagnosis of Lyme Disease Has Devastating Effect on Patients


A nationwide survey by confirms that current methods used to diagnose and treat Lyme disease are often faulty and inadequate.  The overwhelming response rate – over 6,000 respondents within six weeks – demonstrates the urgency of this issue within the Lyme  community.

Sixty-one per cent of those who responded to the survey by reported that it took more than two years for them to receive a correct diagnosis. Only 21% reported being correctly diagnosed within six months of symptom  onset.

“Prompt diagnosis and rapid treatment of Lyme disease can prevent long-term complications,” says San Francisco physician and tick-borne disease expert Dr. Ray Stricker. “When diagnosis is delayed, patients miss out on early treatment. The results can be  devastating.”

Part of the problem, Stricker notes, is the unreliability standard lab testing for Lyme. “The most widely used lab tests for Lyme have been shown to miss more than 50% of cases. That’s no better than a coin  toss.”

Another problem is widespread misunderstanding of where Lyme can be contracted—all 50 states and more than 60 foreign countries.  Almost half (47%) of survey respondents said their Lyme tests were delayed or denied because their physician did not believe the disease was found in their  area.

“I got passed around from specialist to specialist,” commented one survey respondent. “Every single one said that my symptoms sounded like Lyme disease, but they wouldn’t test because they said there is no Lyme in  Utah.”

The study also found significant delays in treatment due to misdiagnosis. “Lyme disease is often called ‘the great imitator’ because it can mimic other diseases so closely,” says Lorraine Johnson, CEO of

Among study respondents, the most prevalent misdiagnosis was mood disorders (59%), followed by Chronic Fatigue (55%) and Fibromyalgia (49%). Johnson pointed out that when people are misdiagnosed, they not only miss out on appropriate Lyme treatment, but they may also be given medications for conditions they don’t have. “Early diagnosis and treatment is an achievable goal that can prevent the disease from becoming chronic,” she added. One respondent stated “It’s sad to see people nonfunctional from tick borne illnesses because they couldn’t get proper treatment from the onset of symptoms when disabilities could have been  avoided.”

The National Institute of Health estimates up to 20% of Lyme patients have symptoms that persist after short-term treatment. The study showed even higher numbers among those with chronic Lyme  disease.

Over 90% reported that their short-term treatment had failed, resulting in chronic illness, which can have a huge impact on quality of life. Of those with chronic Lyme, 73% rated their current quality of life as fair or poor and 42% reported they had to quit working because of Lyme. “This disease has cost me my life, my finances, my ability to contribute to society,” said one 35-year-old female  respondent.

The study was conducted online from a self-selected sampling of Lyme disease patients and their  caretakers.

For more information about Lyme disease:

For a detailed report of survey  results;

About Lyme disease: Lyme disease is a bacterial infection primarily transmitted by ticks. It is found throughout the United States, as well as in more than sixty other countries.  Untreated Lyme disease can result in neurological disorders, crippling muscle and joint pain, heart conditions, disabling fatigue, and psychological disorders.  Even when Lyme disease is caught early and treated with a short course of antibiotics, debilitating symptoms can persist and require additional longer-term  treatment.

The Centers for Disease Control and Prevention estimates that 300,000 people are diagnosed with Lyme disease in the US every year. Lyme disease affects people of all ages and the CDC notes it is most common in children, older adults, and those who spend time in outdoor activities and have higher exposure to  ticks.

About Since 1989, has advocated nationally for quality accessible healthcare for patients with Lyme and other tick-borne diseases. We are committed to shaping health policy through advocacy, legal and ethical analysis, education, physician training, and medical research. Our mission is to prevent Lyme disease, prevent early Lyme disease from becoming chronic, and to obtain access to care for patients with chronic Lyme  disease.


All opinions expressed on USDR are those of the author and not necessarily those of US Daily Review.